Literature DB >> 19962373

Time-of-flight mass spectrometry analysis of the ferroportin-hepcidin binding domain complex for accurate mass confirmation of bioactive hepcidin 25.

David K Crockett, Mark M Kushnir, John D Phillips, Alan L Rockwood.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19962373      PMCID: PMC3816110          DOI: 10.1016/j.cca.2009.11.031

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  15 in total

1.  Novel urine hepcidin assay by mass spectrometry.

Authors:  Erwin Kemna; Harold Tjalsma; Coby Laarakkers; Elizabeta Nemeth; Hans Willems; Dorine Swinkels
Journal:  Blood       Date:  2005-07-19       Impact factor: 22.113

2.  Protein quantification by mass spectrometry: is it ready for prime time?

Authors:  Eleftherios P Diamandis; Samir Hanash; Mary Lopez; Steven Carr; Emanuel F Petricoin
Journal:  Clin Chem       Date:  2009-05-14       Impact factor: 8.327

Review 3.  Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?

Authors:  Dorine W Swinkels; Jack F M Wetzels
Journal:  Nephrol Dial Transplant       Date:  2008-05-21       Impact factor: 5.992

Review 4.  Molecular pathogenesis of anemia of chronic disease.

Authors:  Tomas Ganz
Journal:  Pediatr Blood Cancer       Date:  2006-05-01       Impact factor: 3.167

5.  Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.

Authors:  Joshua Zaritsky; Brian Young; He-Jing Wang; Mark Westerman; Gordana Olbina; Elizabeta Nemeth; Tomas Ganz; Seth Rivera; Allen R Nissenson; Isidro B Salusky
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

6.  Sequential evaluation of serum hepcidin in anemic myeloma patients: study of correlations with myeloma treatment, disease variables, and anemia response.

Authors:  Eirini Katodritou; Tomas Ganz; Evangelos Terpos; Evgenia Verrou; Gordana Olbina; Vassiliki Gastari; Christina Hadjiaggelidou; Maria Varthaliti; Sofia Georgiadou; Mark Westerman; Konstantinos Zervas
Journal:  Am J Hematol       Date:  2009-08       Impact factor: 10.047

7.  The hepcidin-binding site on ferroportin is evolutionarily conserved.

Authors:  Ivana De Domenico; Elizabeta Nemeth; Jenifer M Nelson; John D Phillips; Richard S Ajioka; Michael S Kay; James P Kushner; Tomas Ganz; Diane M Ward; Jerry Kaplan
Journal:  Cell Metab       Date:  2008-08       Impact factor: 27.287

Review 8.  Role of iron in carcinogenesis: cancer as a ferrotoxic disease.

Authors:  Shinya Toyokuni
Journal:  Cancer Sci       Date:  2008-10-23       Impact factor: 6.716

9.  Hepcidin revisited, disulfide connectivity, dynamics, and structure.

Authors:  John B Jordan; Leszek Poppe; Mitsuru Haniu; Tara Arvedson; Rashid Syed; Vivian Li; Hiko Kohno; Helen Kim; Paul D Schnier; Timothy S Harvey; Les P Miranda; Janet Cheetham; Barbra J Sasu
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

10.  Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis.

Authors:  George Papanikolaou; Mark E Samuels; Erwin H Ludwig; Marcia L E MacDonald; Patrick L Franchini; Marie-Pierre Dubé; Lisa Andres; Julie MacFarlane; Nikos Sakellaropoulos; Marianna Politou; Elizabeta Nemeth; Jay Thompson; Jenni K Risler; Catherine Zaborowska; Ryan Babakaiff; Christopher C Radomski; Terry D Pape; Owen Davidas; John Christakis; Pierre Brissot; Gillian Lockitch; Tomas Ganz; Michael R Hayden; Y Paul Goldberg
Journal:  Nat Genet       Date:  2003-11-30       Impact factor: 38.330

View more
  1 in total

1.  Surface plasmon resonance based on molecularly imprinted nanoparticles for the picomolar detection of the iron regulating hormone Hepcidin-25.

Authors:  Lucia Cenci; Erika Andreetto; Ambra Vestri; Michele Bovi; Mario Barozzi; Erica Iacob; Mirko Busato; Annalisa Castagna; Domenico Girelli; Alessandra Maria Bossi
Journal:  J Nanobiotechnology       Date:  2015-08-27       Impact factor: 10.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.